Madrigal Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €153.64M +∞% -€397.38M +24.7% -258.6% -2.6 pp -€387.33M +40.7% -252.1% -2.5 pp
    €0.00 +NaN% -€318.69M +26.5% N/A -€275.29M +43.7% N/A
    €0.00 +NaN% -€251.92M +22.1% N/A -€191.61M +22.3% N/A
    €0.00 +NaN% -€206.28M +19.6% N/A -€156.69M +16.8% N/A
    €0.00 +NaN% -€172.50M +140.9% N/A -€134.11M +279.3% N/A
    €0.00 +NaN% -€71.60M +155.9% N/A -€35.36M +62.7% N/A
    €0.00 +NaN% -€27.99M +5.3% N/A -€21.74M +14.8% N/A
    €0.00 +NaN% -€26.57M +18.1% N/A -€18.93M +26.1% N/A
    €0.00 +NaN% -€22.51M -61.6% N/A -€15.02M -75.3% N/A
    €0.00 +NaN% -€58.57M -20.3% N/A -€60.89M -9.4% N/A
    €0.00 +NaN% -€73.49M -4.5% N/A -€67.20M +2.8% N/A
    €0.00 -100.0% -€76.93M +43.6% N/A -€65.37M +42.9% N/A
    €125.38K -98.1% -€53.56M +32.5% -42,714.3% -420 pp -€45.74M +15.1% -36,483.0% -360 pp
    €6.47M -48.8% -€40.41M +26.5% -624.7% -3.7 pp -€39.76M +22.5% -614.6% -3.6 pp
    €12.63M -89.7% -€31.96M -147.4% -253.1% -3.1 pp -€32.47M +44.4% -257.1% -2.4 pp
    €123.03M +5,416.1% €67.46M -185.4% 54.8% +36 pp -€22.48M -26.3% -18.3% +13 pp
    €2.23M +252.0% -€79.00M +45.9% -3,541.8% +50 pp -€30.50M -220.9% -1,367.3% -53 pp
    €633.74K +∞% -€54.16M +10.9% -8,545.8% -85 pp €25.22M -157.5% 3,980.1% +40 pp
    €0.00 +NaN% -€48.85M -16.8% N/A -€43.85M -9.8% N/A
    €0.00 -100.0% -€58.74M +49.9% N/A -€48.62M +77.0% N/A
    €147.56K -86.7% -€39.18M +64.8% -26,551.4% -240 pp -€27.47M +41.0% -18,613.3% -170 pp
    €1.11M -€23.78M -2,137.9% -€19.48M -1,751.8%

    Notifications